BACKGROUND: An increased incidence of esophageal lesions (EL) after pulmonary vein isolation (PVI) using the second-generation cryoballoon (CB2) has been described. We hypothesized that luminal esophageal temperature (LET)-guided PVI reduces the incidence of EL. OBJECTIVE: The aim of this study was to investigate the incidence of EL after LET-guided PVI using the CB2. METHODS: Ninety-four consecutive patients underwent CB2-PVI for paroxysmal or persistent atrial fibrillation. Target freezing time was 2 × 240 seconds. LET was continuously measured by a probe with 3 thermocouples. Early freezing interruption was performed when LET reached a prespecified cutoff temperature. A group of 32 patients who underwent CB2-PVI with observational LET measurement served as the control group. Postprocedural esophagoscopy was performed in all patients. RESULTS: Compared with observational LET measurement, a strategy of LET-guided CB-PVI significantly reduced the incidence of EL from 18.8% to 3.2% (P = .008). A progressive decline in the incidence of EL was observed with an increasing LET cutoff: 7.1% (2/28 patients, 12°C cutoff) and 1.5% (1/66 patients, 15°C cutoff, P = .005 vs control). Despite early freezing interruption at a single pulmonary vein in 27% (25/94) of patients, complete PVI was achieved in all patients using the 28 mm balloon. Repeat esophagoscopy confirmed healing of EL after 1 week. After a mean of 268 ± 119 days, 87% (76/87) of patients were free of recurrent atrial fibrillation or atrial tachycardia following a 90-days blanking period. CONCLUSION: LET-guided CB2-PVI significantly reduced the incidence of thermal EL. Interrupting cryoablation at 15°C LET was associated with the lowest incidence of esophageal injury.
BACKGROUND: An increased incidence of esophageal lesions (EL) after pulmonary vein isolation (PVI) using the second-generation cryoballoon (CB2) has been described. We hypothesized that luminal esophageal temperature (LET)-guided PVI reduces the incidence of EL. OBJECTIVE: The aim of this study was to investigate the incidence of EL after LET-guided PVI using the CB2. METHODS: Ninety-four consecutive patients underwent CB2-PVI for paroxysmal or persistent atrial fibrillation. Target freezing time was 2 × 240 seconds. LET was continuously measured by a probe with 3 thermocouples. Early freezing interruption was performed when LET reached a prespecified cutoff temperature. A group of 32 patients who underwent CB2-PVI with observational LET measurement served as the control group. Postprocedural esophagoscopy was performed in all patients. RESULTS: Compared with observational LET measurement, a strategy of LET-guided CB-PVI significantly reduced the incidence of EL from 18.8% to 3.2% (P = .008). A progressive decline in the incidence of EL was observed with an increasing LET cutoff: 7.1% (2/28 patients, 12°C cutoff) and 1.5% (1/66 patients, 15°C cutoff, P = .005 vs control). Despite early freezing interruption at a single pulmonary vein in 27% (25/94) of patients, complete PVI was achieved in all patients using the 28 mm balloon. Repeat esophagoscopy confirmed healing of EL after 1 week. After a mean of 268 ± 119 days, 87% (76/87) of patients were free of recurrent atrial fibrillation or atrial tachycardia following a 90-days blanking period. CONCLUSION: LET-guided CB2-PVI significantly reduced the incidence of thermal EL. Interrupting cryoablation at 15°C LET was associated with the lowest incidence of esophageal injury.
Authors: Shaojie Chen; Boris Schmidt; Stefano Bordignon; Fabrizio Bologna; Takahiko Nagase; Laura Perrotta; K R Julian Chun Journal: Arrhythm Electrophysiol Rev Date: 2018-03
Authors: Giacomo Mugnai; Darragh Moran; Erwin Ströker; Diego Ruggiero; Hugo Enrique Coutino-Moreno; Ken Takarada; Valentina De Regibus; Rajin Choudhury; Saverio Iacopino; Pasquale Filannino; Vincent Umbrain; Stefan Beckers; Pedro Brugada; Carlo de Asmundis; Gian-Battista Chierchia Journal: J Interv Card Electrophysiol Date: 2016-08-15 Impact factor: 1.900
Authors: Christian-H Heeger; Erik Wissner; Shibu Mathew; Kentaro Hayashi; Christian Sohns; Bruno Reißmann; Christine Lemes; Tilmann Maurer; Thomas Fink; Ardan M Saguner; Francesco Santoro; Johannes Riedl; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: Clin Res Cardiol Date: 2015-11-25 Impact factor: 5.460
Authors: Philipp Seidl; Frank Steinborn; Lisa Costello-Boerrigter; Ralf Surber; Paul C Schulze; Christine Böttcher; Andreas Sommermeier; Violeta Mattea; Roland Simeoni; Frank Michael Malur; Harald Lapp; Anja Schade Journal: J Interv Card Electrophysiol Date: 2020-05-15 Impact factor: 1.900
Authors: Christopher A B Kowalewski; Miguel Rodrigo; Chad Brodt; Francois Haddad; Paul J Wang; Sanjiv M Narayan Journal: Pacing Clin Electrophysiol Date: 2020-02-17 Impact factor: 1.976